ニュース
Alibaba reported a 93% YoY increase in operating income for the March 2025 quarter, driven by strong cloud revenue and sustained triple-digit growth in AI products. Total revenue rose 7% to RMB 236.5 ...
SINGAPORE] Local stocks climbed on Thursday (May 15), as investors assessed financial results from listed companies here.
Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.
City’s largest share sale in four years shows Beijing’s determination to push China’s EV technologies worldwide, analysts say ...
Jiangsu Hengrui, a 55-year-old drugmaker that has become one of China’s leading forces in biotech, expects net proceeds of about 9.4 billion Hong Kong dollars … ...
The underwriters on Hengrui Pharmaceutical Hong Kong listing are represented by Herbert Smith Freehills and Jingtian & ...
香港への重複上場に向けて、中国の車載電池大手、寧徳時代新能源科技(CATL)が計画している新規株式公開(IPO)は約40億ドルと、今年これまでで世界最大規模になる見通しだが、米国本土の投資家は募集対象から除外されている。これによってCATLは、さまざ ...
Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.
Hong Kong is calling for robotaxi operator Pony AI . The $6 billion Chinese company is exploring an offering in the city just ...
Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.
And another scoop: Two of FTI Consulting’s top economics experts in Europe have left to join Jonathan Orszag’s upstart rival ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する